Aptevo Therapeutics (APVO) Institutional Ownership $1.64 -0.06 (-3.53%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$1.64 +0.01 (+0.30%) As of 08/29/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Aptevo Therapeutics (NASDAQ:APVO)CurrentInstitutional OwnershipPercentage8.06%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$30.50KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$1.75M Get APVO Insider Trade Alerts Want to know when executives and insiders are buying or selling Aptevo Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data APVO Institutional Buying and Selling by Quarter Aptevo Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 Birchview Capital LP10,000$30K0.0%N/A1.316% 2/11/2025 Virtu Financial LLC21,627$93K0.0%-48.5%4.241% 8/15/2024 Armistice Capital LLC749,234$229K0.0%N/A18.359% 11/15/2023 Sabby Management LLC1,334,169$440K0.3%N/A11.581% 11/15/2023 Armistice Capital LLC1,235,000$408K0.0%N/A10.717% 2/1/2023 Bank of Montreal Can10,000$61K0.0%N/A0.196% 11/15/2022 Cantor Fitzgerald L. P.133,700$406K0.0%N/A2.627% 11/7/2022 Virtu Financial LLC28,421$86K0.0%+122.6%0.558% 12/10/2021 Towercrest Capital Management211,227$3.26M0.6%N/A4.313% 12/8/2021 Moors & Cabot Inc.389,269$3.73M0.2%N/A7.948% Get the Latest News and Ratings for APVO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aptevo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/15/2021 Franklin Resources Inc.15,650$242K0.0%N/A0.320% 11/15/2021 GSA Capital Partners LLP13,651$211K0.0%N/A0.279% 11/12/2021 Renaissance Technologies LLC143,419$2.21M0.0%-10.3%2.931% 11/9/2021BlackRock Inc.55,394$856K0.0%+1.9%1.133% 11/5/2021 Moors & Cabot Inc.389,269$3.73M0.3%N/A7.954% 8/17/2021 Balyasny Asset Management LLC18,012$404K0.0%-70.6%0.405% 8/17/2021 Boothbay Fund Management LLC15,350$344K0.0%+4.9%0.345% 8/16/2021 Alyeska Investment Group L.P.139,172$3.12M0.0%-80.9%3.127% 8/16/2021 Morgan Stanley8,364$187K0.0%+163.4%0.188% 8/16/2021 Kennedy Capital Management Inc.187,995$4.22M0.1%N/A4.225% 8/16/2021 State Street Corp10,973$246K0.0%N/A0.247% 8/13/2021 Renaissance Technologies LLC159,923$3.59M0.0%-23.6%3.594% 8/13/2021 Anson Funds Management LP35,587$798K0.1%-26.6%0.800% 8/13/2021 Northern Trust Corp22,652$508K0.0%+170.7%0.509% 8/13/2021QS Investors LLC15,650$352K0.0%+37.3%0.352% 8/13/2021 Geode Capital Management LLC38,917$872K0.0%+8.8%0.875% 8/13/2021 Vanguard Group Inc.134,760$3.02M0.0%+2.9%3.028% (Data available from 1/1/2016 forward) APVO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of APVO shares? During the previous two years, the following institutional investors and hedge funds held shares of Aptevo Therapeutics shares: Sabby Management LLC ($440K), Armistice Capital LLC ($229K), and Virtu Financial LLC ($93K), Birchview Capital LP ($30K).Learn more on Aptevo Therapeutics' institutional investors. What percentage of Aptevo Therapeutics' stock is owned by institutional investors? 8.06% of Aptevo Therapeutics' stock is owned by institutional investors. Learn more on APVO's institutional investor holdings. Which institutional investors have been buying Aptevo Therapeutics' stock? The following institutional investors have purchased Aptevo Therapeutics' stock in the last 24 months: Armistice Capital LLC ($1.98M), Sabby Management LLC ($1.33M), and Birchview Capital LP ($10K). How much institutional buying is happening at Aptevo Therapeutics? Institutional investors have bought a total of 10,000 shares in the last 24 months. This purchase volume represents approximately $30.50K in transactions. Which of Aptevo Therapeutics' major shareholders have been selling company stock? The following institutional investors have sold Aptevo Therapeutics stock in the last 24 months: Virtu Financial LLC ($20.34K). How much institutional selling is happening at Aptevo Therapeutics? Institutional investors have sold a total of 20,340 shares in the last 24 months. This volume of shares sold represents approximately $1.75M in transactions. Related Companies CVKD Major Shareholders ENLV Major Shareholders FBLG Major Shareholders NAII Major Shareholders PASG Major Shareholders NNVC Major Shareholders SONN Major Shareholders QTTB Major Shareholders CTXR Major Shareholders CING Major Shareholders This page (NASDAQ:APVO) was last updated on 8/31/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aptevo Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aptevo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free APVO Stock Alerts